Lymphatic and blood vessels in scleroderma skin, a morphometric analysis

[1]  Paul C. Gorski The Myth , 2022, Nkrumah and the Ghana Revolution.

[2]  J. Seibold,et al.  Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin". , 2010, Arthritis and rheumatism.

[3]  B. Mehrara,et al.  TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. , 2008, American journal of physiology. Heart and circulatory physiology.

[4]  A. Herrick,et al.  High circulating levels of VEGF-C suggest abnormal lymphangiogenesis in systemic sclerosis. , 2008, Rheumatology.

[5]  R. Gomer Circulating progenitor cells and scleroderma , 2008, Current rheumatology reports.

[6]  Hiroshi I. Suzuki,et al.  Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. , 2008, Blood.

[7]  S. Schwartz,et al.  The pathology of scleroderma vascular disease. , 2008, Rheumatic diseases clinics of North America.

[8]  B. Kahaleh Vascular disease in scleroderma: mechanisms of vascular injury. , 2008, Rheumatic diseases clinics of North America.

[9]  M. Simons,et al.  Vascular disease in scleroderma: angiogenesis and vascular repair. , 2008, Rheumatic diseases clinics of North America.

[10]  Stephen M. Schwartz,et al.  Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype? , 2008, PloS one.

[11]  J. Chung,et al.  Reduction of lymphatic vessels in photodamaged human skin. , 2007, Journal of dermatological science.

[12]  D. Abraham,et al.  How does endothelial cell injury start? The role of endothelin in systemic sclerosis , 2007, Arthritis research & therapy.

[13]  P. Helmbold,et al.  Radiogenic lymphangiogenesis in the skin. , 2007, The American journal of pathology.

[14]  K. Alitalo,et al.  Molecular regulation of angiogenesis and lymphangiogenesis , 2007, Nature Reviews Molecular Cell Biology.

[15]  David Abraham,et al.  Systemic sclerosis: a prototypic multisystem fibrotic disorder. , 2007, The Journal of clinical investigation.

[16]  Brady T. West,et al.  Linear Mixed Models: A Practical Guide Using Statistical Software , 2006 .

[17]  M. Detmar,et al.  New insights into the molecular control of the lymphatic vascular system and its role in disease. , 2006, The Journal of investigative dermatology.

[18]  A. Gabrielli,et al.  Bone marrow endothelial progenitors are defective in systemic sclerosis. , 2006, Arthritis and rheumatism.

[19]  Meit A. Bjorndahl,et al.  Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. , 2005, Blood.

[20]  M. Detmar,et al.  Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. , 2005, The American journal of pathology.

[21]  D. Hicklin,et al.  Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. , 2004, Blood.

[22]  Y. Ikeda,et al.  Defective vasculogenesis in systemic sclerosis , 2004, The Lancet.

[23]  Till Acker,et al.  Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis , 2004, Circulation research.

[24]  P. Qu,et al.  Expression of VEGFR‐3 and 5′‐Nase in regenerating lymphatic vessels of the cutaneous wound healing , 2004, Microscopy research and technique.

[25]  A Sulli,et al.  Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. , 2004, Rheumatology.

[26]  H. Takiwaki,et al.  Intravascular or intralymphatic histiocytosis associated with rheumatoid arthritis: a report of 4 cases. , 2004, Journal of the American Academy of Dermatology.

[27]  T. Ryan The ageing of the blood supply and the lymphatic drainage of the skin. , 2004, Micron.

[28]  Shin-Seok Lee,et al.  Elevated vascular endothelial growth factor in systemic sclerosis. , 2003, The Journal of rheumatology.

[29]  Y. Konttinen,et al.  Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin. , 2002, Clinical and experimental rheumatology.

[30]  Alexander Marks,et al.  A New Monoclonal Antibody, D2-40, for Detection of Lymphatic Invasion in Primary Tumors , 2002, Laboratory Investigation.

[31]  M. Conforti,et al.  Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers , 2002, Arthritis research.

[32]  P. Carmeliet,et al.  Conditional switching of VEGF provides new insights into adult neovascularization and pro‐angiogenic therapy , 2002, The EMBO journal.

[33]  G. Strutton,et al.  Cutaneous histiocytic lymphangitis: An unusual manifestation of rheumatoid arthritis , 2000, The Australasian journal of dermatology.

[34]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[35]  P. Bruehlmann,et al.  Lymphatic microangiopathy of the skin in systemic sclerosis. , 1999, Rheumatology.

[36]  E. Leroy SYSTEMIC SCLEROSIS : A Vascular Perspective , 1996 .

[37]  C. Kallenberg,et al.  Early detection of connective tissue disease in patients with Raynaud's phenomenon. , 1990, Rheumatic diseases clinics of North America.

[38]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[39]  Geert Molenberghs,et al.  Linear Mixed Models , 2011, International Encyclopedia of Statistical Science.

[40]  Y. Konttinen,et al.  Variations of neuronal nitric oxide synthase in systemic sclerosis skin. , 2006, Arthritis and rheumatism.

[41]  R. Scorza,et al.  Assessment of vascular involvement. , 2003, Clinical and experimental rheumatology.

[42]  A. Damião,et al.  Protein-losing enteropathy in systemic lupus erythematosus. , 1991, Revista do Hospital das Clinicas.